Objectives: At the end of this program, participants should be able to:

1. Review rationale for minimally invasive surgery in ICH, and prior clinical trials.

2. Present optimizations of the procedure prior to MISTIE III.

3. MISTIE III Results and who benefited.

4. Levels of evidence, lessons learned and the road ahead.

Session date: 
03/27/2019 - 8:30am to 9:30am CDT
UCMC M-137
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Issam A. Awad, MD, MSc, FACS, MA (hon)